Amarin Corp Plcuk (AMRN) Long-Term Deferred Tax (2010 - 2017)
Amarin Corp Plcuk (AMRN) reported Long-Term Deferred Tax of $11.1 million for Q3 2017, down 51.83% year-over-year from $23.0 million in Q3 2016, and little changed quarter-over-quarter from $11.1 million in Q2 2017.
Amarin Corp Plcuk (AMRN) Long-Term Deferred Tax (2010 - 2017) Analysis & Trends
Amarin Corp Plcuk (AMRN) has 8 years of Long-Term Deferred Tax data on file, last reported at $11.1 million in Q3 2017.
- Long-Term Deferred Tax for Q3 2017 came in at $11.1 million, down 51.83% year-over-year; the trailing twelve-month figure through Sep 2017 was $11.1 million (down 51.83% YoY), and the FY2016 annual result was $11.1 million, down 44.23% from the prior year.
- Long-Term Deferred Tax steadied at $11.1 million in Q3 2017 per AMRN's latest filing, from $11.1 million in the prior quarter.
- Over five years, Long-Term Deferred Tax peaked at $23.0 million in Q3 2016 and troughed at $11.1 million in Q4 2016.
- A 5-year average of $14.1 million and a median of $12.6 million in 2014 frame the typical range for Long-Term Deferred Tax.
- The sharpest annual moves came in 2016 and 2017: Long-Term Deferred Tax jumped 63.45% in 2016, then sank 51.83% in 2017.
- A 5-year view of Long-Term Deferred Tax shows it stood at $11.9 million in 2013, then advanced by 5.12% to $12.6 million in 2014, then jumped by 58.27% to $19.9 million in 2015, then tumbled by 44.23% to $11.1 million in 2016, then changed by 0.0% to $11.1 million in 2017.
- Business Quant data shows AMRN's Long-Term Deferred Tax at $11.1 million in Q3 2017, $11.1 million in Q2 2017, and $11.1 million in Q1 2017.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Gsk | 93,699,046.73 Bn | 93,699,041.77 Bn | 7.76 Bn |
| 2 | Eli Lilly | 1,012.06 Bn | 1,006.77 Bn | 16.22 Bn |
| 3 | Johnson & Johnson | 560.67 Bn | 538.62 Bn | 15.96 Bn |
| 4 | AbbVie | 402.20 Bn | 392.85 Bn | 10.78 Bn |
| 5 | Merck | 298.59 Bn | 292.94 Bn | 12.09 Bn |
| 6 | Amgen | 188.77 Bn | 176.74 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 160.22 Bn | 152.49 Bn | 5.52 Bn |
| 8 | Pfizer | 148.19 Bn | 135.42 Bn | -1.21 Bn |
| 9 | Bristol Myers Squibb | 116.72 Bn | 106.26 Bn | 8.07 Bn |
| 10 | Amarin Corp Plcuk | 5.84 Bn | 5.66 Bn | 17.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2017 | 11.08 Mn |
| Jun 30, 2017 | 11.08 Mn |
| Mar 31, 2017 | 11.08 Mn |
| Dec 31, 2016 | 11.08 Mn |
| Sep 30, 2016 | 23.01 Mn |
| Jun 30, 2016 | 21.72 Mn |
| Mar 31, 2016 | 18.68 Mn |
| Dec 31, 2015 | 19.87 Mn |
| Sep 30, 2015 | 14.14 Mn |
| Jun 30, 2015 | 13.29 Mn |
| Mar 31, 2015 | 12.65 Mn |
| Dec 31, 2014 | 12.56 Mn |
| Sep 30, 2014 | 11.86 Mn |
| Jun 30, 2014 | 11.94 Mn |
| Mar 31, 2014 | 11.97 Mn |
| Dec 31, 2013 | 11.94 Mn |
| Sep 30, 2013 | 14.43 Mn |
| Jun 30, 2013 | 12.88 Mn |
| Mar 31, 2013 | 11.99 Mn |
| Dec 31, 2012 | 8.04 Mn |